These results suggest that exposure to DEN attenuates leukemia cell migration likely through the inhibition of the CXCR4-CXCL-12 axis rather than AML cell adhesion to the extracellular matrix in vitro. The gene discussed is CXCL12; the disease is acute myeloid leukemia.